Encompass Health Co. (NYSE:EHC) Shares Acquired by Atom Investors LP

Atom Investors LP boosted its holdings in Encompass Health Co. (NYSE:EHC) by 460.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 40,829 shares of the company’s stock after purchasing an additional 33,544 shares during the quarter. Atom Investors LP’s holdings in Encompass Health were worth $3,946,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new position in Encompass Health during the first quarter worth approximately $208,000. Cetera Advisors LLC purchased a new position in Encompass Health in the first quarter valued at approximately $291,000. GAMMA Investing LLC lifted its position in Encompass Health by 92.2% during the second quarter. GAMMA Investing LLC now owns 1,184 shares of the company’s stock valued at $102,000 after buying an additional 568 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after buying an additional 26,270 shares during the period. Finally, CWM LLC increased its position in shares of Encompass Health by 6.3% in the second quarter. CWM LLC now owns 6,388 shares of the company’s stock worth $548,000 after acquiring an additional 379 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research reports. Barclays upped their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group increased their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada boosted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp increased their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Finally, Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Price Performance

Shares of EHC opened at $102.94 on Monday. Encompass Health Co. has a 52 week low of $63.78 and a 52 week high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market cap of $10.37 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 1.36 and a beta of 0.88. The stock has a 50 day moving average of $98.16 and a 200-day moving average of $91.42.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the previous year, the firm earned $0.86 earnings per share. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.